BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26509588)

  • 1. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.
    Nowak N; Skupien J; Niewczas MA; Yamanouchi M; Major M; Croall S; Smiles A; Warram JH; Bonventre JV; Krolewski AS
    Kidney Int; 2016 Feb; 89(2):459-67. PubMed ID: 26509588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N; Skupien J; Smiles AM; Yamanouchi M; Niewczas MA; Galecki AT; Duffin KL; Breyer MD; Pullen N; Bonventre JV; Krolewski AS
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.
    Krolewski AS; Niewczas MA; Skupien J; Gohda T; Smiles A; Eckfeldt JH; Doria A; Warram JH
    Diabetes Care; 2014; 37(1):226-34. PubMed ID: 23939543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac autonomic neuropathy and early progressive renal decline in patients with nonmacroalbuminuric type 1 diabetes.
    Orlov S; Cherney DZ; Pop-Busui R; Lovblom LE; Ficociello LH; Smiles AM; Warram JH; Krolewski AS; Perkins BA
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1136-44. PubMed ID: 26092828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome.
    Emmens JE; Ter Maaten JM; Matsue Y; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; Todd J; van Veldhuisen DJ; Hillege HL; Damman K; van der Meer P; Voors AA
    Eur J Heart Fail; 2016 Jun; 18(6):641-9. PubMed ID: 26511274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
    Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
    Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
    Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients.
    van Timmeren MM; Vaidya VS; van Ree RM; Oterdoom LH; de Vries AP; Gans RO; van Goor H; Stegeman CA; Bonventre JV; Bakker SJ
    Transplantation; 2007 Dec; 84(12):1625-30. PubMed ID: 18165774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.
    Perkins BA; Ficociello LH; Ostrander BE; Silva KH; Weinberg J; Warram JH; Krolewski AS
    J Am Soc Nephrol; 2007 Apr; 18(4):1353-61. PubMed ID: 17329575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
    Perkins BA; Rabbani N; Weston A; Ficociello LH; Adaikalakoteswari A; Niewczas M; Warram J; Krolewski AS; Thornalley P
    PLoS One; 2012; 7(4):e35655. PubMed ID: 22558190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of obesity and type 1 diabetes on renal function in children and adolescents.
    Franchini S; Savino A; Marcovecchio ML; Tumini S; Chiarelli F; Mohn A
    Pediatr Diabetes; 2015 Sep; 16(6):427-33. PubMed ID: 25131409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kidney injury molecule 1 and incidence of heart failure in elderly men.
    Carlsson AC; Larsson A; Helmersson-Karlqvist J; Lind L; Ingelsson E; Larsson TE; Sundström J; Arnlöv J
    Eur J Heart Fail; 2013 Apr; 15(4):441-6. PubMed ID: 23220287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.
    Waanders F; Vaidya VS; van Goor H; Leuvenink H; Damman K; Hamming I; Bonventre JV; Vogt L; Navis G
    Am J Kidney Dis; 2009 Jan; 53(1):16-25. PubMed ID: 18823687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.
    Niewczas MA; Ficociello LH; Johnson AC; Walker W; Rosolowsky ET; Roshan B; Warram JH; Krolewski AS
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):62-70. PubMed ID: 19073786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.
    Panduru NM; Sandholm N; Forsblom C; Saraheimo M; Dahlström EH; Thorn LM; Gordin D; Tolonen N; Wadén J; Harjutsalo V; Bierhaus A; Humpert PM; Groop PH;
    Diabetes Care; 2015 Jun; 38(6):1130-7. PubMed ID: 25784666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease.
    Gohda T; Kamei N; Koshida T; Kubota M; Tanaka K; Yamashita Y; Adachi E; Ichikawa S; Murakoshi M; Ueda S; Suzuki Y
    J Diabetes Investig; 2020 Mar; 11(2):435-440. PubMed ID: 31483944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney injury molecule-1 correlates with kidney function in renal allograft recipients.
    Malyszko J; Koc-Zorawska E; Malyszko JS; Mysliwiec M
    Transplant Proc; 2010 Dec; 42(10):3957-9. PubMed ID: 21168598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.